
- Home
- Research Models
- CBA/JCrHsd
CBA/JCrHsd
Related publications
Immunology
Other
Immunology
Nomile, T., Rella, A., Del Poeta, M.,
Cryptococcus neoformans ?sgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection,
Front. Cell. Infect. Microbiol., 08 September 2021
Bryan, Arielle M., Jeehyun Karen You, Travis McQuiston, Cristina Lazzarini, Zhijuan Qiu, Brian Sheridan, Barbara Nuesslein-Hildesheim, and Maurizio Del Poeta.,
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages,
J Clin Invest. 2020;130(9):4546-4560.
Other
Lazzarini, C., Haranahalli, K., McCarthy, J.B., Mallamo, J., Ojima, I. and Del Poeta, M.,
Preclinical Evaluation of Acylhydrazone SB-AF-1002 as a Novel Broad-Spectrum Antifungal Agent,
Antimicrobial Agents and Chemotherapy 64, no. 9 (2020): e00946-20.
Bernstock, Joshua D., Nunzio Vicario, Rong Li, Li Nan, Stacie K. Totsch, Charles Schlappi, Florian Gessler et al.,
Safety and Efficacy of Oncolytic HSV-1 G207 Inoculated into the Cerebellum of Mice,
Cancer gene therapy 27, no. 3 (2020): 246-255.
Pereira de Sa, N., Taouil, A., Kim, J. et al.,
Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents,
Nat Commun 12, 5885 (2021).
Vilchčze, Catherine, and William R. Jacobs Jr.,
The Promises and Limitations of N-Acetylcysteine as a Potentiator of First-Line and Second-Line Tuberculosis Drugs,
Antimicrobial agents and chemotherapy 65, no. 5 (2021): e01703-20.